Preconditioning of murine mesenchymal stem cells synergistically enhanced immunomodulation and osteogenesis

Stem Cell Research & Therapy

Tzuhua Lin¹  Karthik Nathan¹  Stuart B. Goodman¹  Laura Lu¹  Jukka Pajarinen¹  Zhenyu Yao¹  Akira Nabeshima¹  Eemeli Jämsen¹ 

[1] Department of Orthopaedic Surgery, Stanford University School of Medicine;

关键词: Mesenchymal stem cells;    Immunomodulation;    Macrophage polarization;    Osteogenesis;    Prostaglandin E2;   

DOI  :  10.1186/s13287-017-0730-z

来源: DOAJ

【 摘 要 】

Abstract Background Mesenchymal stem cells (MSCs) are capable of immunomodulation and tissue regeneration, highlighting their potential translational application for treating inflammatory bone disorders. MSC-mediated immunomodulation is regulated by proinflammatory cytokines and pathogen-associated molecular patterns such as lipopolysaccharide (LPS). Previous studies showed that MSCs exposed to interferon gamma (IFN-γ) and the proinflammatory cytokine tumor necrosis factor alpha (TNF-α) synergistically suppressed T-cell activation. Methods In the current study, we developed a novel preconditioning strategy for MSCs using LPS plus TNF-α to optimize the immunomodulating ability of MSCs on macrophage polarization. Results Preconditioned MSCs enhanced anti-inflammatory M2 macrophage marker expression (Arginase 1 and CD206) and decreased inflammatory M1 macrophage marker (TNF-α/IL-1Ra) expression using an in-vitro coculture model. Immunomodulation of MSCs on macrophages was significantly increased compared to the combination of IFN-γ plus TNF-α or single treatment controls. Increased osteogenic differentiation including alkaline phosphate activity and matrix mineralization was only observed in the LPS plus TNF-α preconditioned MSCs. Mechanistic studies showed that increased prostaglandin E2 (PGE2) production was associated with enhanced Arginase 1 expression. Selective cyclooxygenase-2 inhibition by Celecoxib decreased PGE2 production and Arginase 1 expression in cocultured macrophages. Conclusions The novel preconditioned MSCs have increased immunomodulation and bone regeneration potential and could be applied to the treatment of inflammatory bone disorders including periprosthetic osteolysis, fracture healing/nonunions, and osteonecrosis.

【 授权许可】

Unknown